Edwards Lifesciences Revenue 2010-2022 | EW

Edwards Lifesciences annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Edwards Lifesciences revenue for the quarter ending September 30, 2022 was $1.319B, a 0.67% increase year-over-year.
  • Edwards Lifesciences revenue for the twelve months ending September 30, 2022 was $5.364B, a 5.29% increase year-over-year.
  • Edwards Lifesciences annual revenue for 2021 was $5.233B, a 19.29% increase from 2020.
  • Edwards Lifesciences annual revenue for 2020 was $4.386B, a 0.88% increase from 2019.
  • Edwards Lifesciences annual revenue for 2019 was $4.348B, a 16.79% increase from 2018.
Edwards Lifesciences Annual Revenue
(Millions of US $)
2021 $5,233
2020 $4,386
2019 $4,348
2018 $3,723
2017 $3,435
2016 $2,964
2015 $2,494
2014 $2,323
2013 $2,046
2012 $1,900
2011 $1,679
2010 $1,447
2009 $1,321
Edwards Lifesciences Quarterly Revenue
(Millions of US $)
2022-09-30 $1,319
2022-06-30 $1,374
2022-03-31 $1,341
2021-12-31 $1,330
2021-09-30 $1,310
2021-06-30 $1,376
2021-03-31 $1,217
2020-12-31 $1,192
2020-09-30 $1,141
2020-06-30 $925
2020-03-31 $1,129
2019-12-31 $1,174
2019-09-30 $1,094
2019-06-30 $1,087
2019-03-31 $993
2018-12-31 $978
2018-09-30 $907
2018-06-30 $944
2018-03-31 $895
2017-12-31 $889
2017-09-30 $822
2017-06-30 $842
2017-03-31 $884
2016-12-31 $768
2016-09-30 $739
2016-06-30 $759
2016-03-31 $697
2015-12-31 $671
2015-09-30 $616
2015-06-30 $617
2015-03-31 $590
2014-12-31 $618
2014-09-30 $607
2014-06-30 $575
2014-03-31 $522
2013-12-31 $536
2013-09-30 $496
2013-06-30 $517
2013-03-31 $497
2012-12-31 $511
2012-09-30 $448
2012-06-30 $482
2012-03-31 $459
2011-12-31 $430
2011-09-30 $413
2011-06-30 $431
2011-03-31 $405
2010-12-31 $392
2010-09-30 $349
2010-06-30 $365
2010-03-31 $341
2009-12-31 $347
2009-09-30 $326
2009-06-30 $336
2009-03-31 $314
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $46.932B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Globus Medical (GMED) United States $7.103B 36.11
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00